USD 0.07
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 31.69 Million SEK | -44.19% |
2022 | 56.78 Million SEK | -5.21% |
2021 | 59.9 Million SEK | -3.03% |
2020 | 61.77 Million SEK | 0.02% |
2019 | 61.76 Million SEK | 300.27% |
2018 | 15.43 Million SEK | 10.42% |
2017 | 13.97 Million SEK | 106.15% |
2016 | 6.77 Million SEK | -12.06% |
2015 | 7.7 Million SEK | 146.21% |
2014 | 3.13 Million SEK | 23.92% |
2013 | 2.52 Million SEK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 27.32 Million SEK | -13.76% |
2024 Q2 | 38.56 Million SEK | 41.1% |
2023 Q3 | 56.37 Million SEK | -4.18% |
2023 FY | 31.69 Million SEK | -44.19% |
2023 Q2 | 58.83 Million SEK | 0.17% |
2023 Q1 | 58.73 Million SEK | 3.42% |
2023 Q4 | 31.69 Million SEK | -43.79% |
2022 Q3 | 64.54 Million SEK | -0.55% |
2022 FY | 56.78 Million SEK | -5.21% |
2022 Q1 | 62.48 Million SEK | 4.31% |
2022 Q2 | 64.9 Million SEK | 3.86% |
2022 Q4 | 56.78 Million SEK | -12.02% |
2021 Q1 | 64.29 Million SEK | 4.08% |
2021 FY | 59.9 Million SEK | -3.03% |
2021 Q4 | 59.9 Million SEK | -11.1% |
2021 Q3 | 67.38 Million SEK | -11.24% |
2021 Q2 | 75.91 Million SEK | 18.08% |
2020 Q3 | 64.01 Million SEK | -2.7% |
2020 Q1 | 66.33 Million SEK | 7.41% |
2020 Q4 | 61.77 Million SEK | -3.5% |
2020 FY | 61.77 Million SEK | 0.02% |
2020 Q2 | 65.79 Million SEK | -0.81% |
2019 Q1 | 55.92 Million SEK | 262.47% |
2019 Q4 | 61.76 Million SEK | 7.73% |
2019 Q2 | 56.54 Million SEK | 1.1% |
2019 FY | 61.76 Million SEK | 300.27% |
2019 Q3 | 57.33 Million SEK | 1.39% |
2018 Q4 | 15.43 Million SEK | 12.8% |
2018 FY | 15.43 Million SEK | 10.42% |
2018 Q3 | 13.67 Million SEK | -40.18% |
2018 Q1 | 14.39 Million SEK | 3.04% |
2018 Q2 | 22.86 Million SEK | 58.82% |
2017 Q2 | 9.76 Million SEK | 28.88% |
2017 FY | 13.97 Million SEK | 106.15% |
2017 Q4 | 13.97 Million SEK | 72.75% |
2017 Q3 | 8.08 Million SEK | -17.19% |
2017 Q1 | 7.57 Million SEK | 11.81% |
2016 Q2 | 5.62 Million SEK | 0.0% |
2016 FY | 6.77 Million SEK | -12.06% |
2016 Q1 | - SEK | -100.0% |
2016 Q4 | 6.77 Million SEK | 0.0% |
2015 Q1 | 6 Million SEK | 91.93% |
2015 Q2 | 6 Million SEK | 0.0% |
2015 Q4 | 7.7 Million SEK | 0.0% |
2015 Q3 | 7.7 Million SEK | 28.28% |
2015 FY | 7.7 Million SEK | 146.21% |
2014 Q1 | - SEK | 0.0% |
2014 Q4 | 3.13 Million SEK | 0.0% |
2014 Q3 | 3.13 Million SEK | 0.0% |
2014 FY | 3.13 Million SEK | 23.92% |
2013 FY | 2.52 Million SEK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Bio Medica Corporation | 3.6 Million USD | -778.326% |
Arrayit Corporation | 7.49 Million USD | -322.725% |
Atlantic International Corp. | 3.82 Million USD | -727.714% |
Biocept, Inc. | 22.01 Million USD | -43.96% |
Bioqual, Inc. | 18.93 Million USD | -67.336% |
CardioGenics Holdings Inc | 1.79 Million USD | -1665.535% |
DermTech, Inc. | 64.75 Million USD | 51.062% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 95.688% |
HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -155.854% |
iMD Companies, Inc. | 1.67 Million USD | -1792.826% |
IDenta Corp. | 1.01 Million USD | -3027.844% |
Interpace Biosciences, Inc. | 28.15 Million USD | -12.548% |
Integrative Health Technologies, Inc. | 297.94 Thousand USD | -10536.12% |
InVitro International | 78.99 Thousand USD | -40019.002% |
Lumos Diagnostics Holdings Limited | 19.72 Million USD | -60.626% |
Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -24409.463% |
Medical Imaging Corp. | 9.51 Million USD | -232.98% |
NovelStem International Corp. | 4.2 Million USD | -653.433% |
Optigenex Inc. | 9.57 Million USD | -231.118% |
PharmChem, Inc. | 558.64 Thousand USD | -5572.634% |
Proteome Sciences plc | 18.48 Million USD | -71.399% |
Response Genetics, Inc | 15.86 Million USD | -99.723% |
Rennova Health, Inc. | 49.66 Million USD | 36.196% |
RushNet, Inc. | 6.23 Million USD | -407.935% |
ScreenPro Security Inc. | 1.6 Million USD | -1879.899% |
Stella Diagnostics Inc. | 18 Million USD | -76.003% |
StageZero Life Sciences Ltd. | 8.2 Million USD | -286.276% |
Todos Medical Ltd. | 50.15 Million USD | 36.818% |